Dose Dependent Biological Effects of Idarubicin in HL-60 Cells: Alterations of the Cell-Cycle and Apoptosis
TP-53 deficient cells of human leukaemia HL-60 die by massive apoptosis after treatment by high (50-100 nmol/l) doses of DNA damaging agent Idarubicin, regardless of the cell-cycle phase, in which they are affected. In contrary, after relatively low dose 10 nmol/l the cells die after cell-cycle arre...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Karolinum Press
2000-01-01
|
Series: | Acta Medica |
Subjects: | |
Online Access: | https://actamedica.lfhk.cuni.cz/43/2/0069/ |